(B) Schematic represents the isolation and labeling of nuclei from post-mortem frozen brain samples from controls and Alzheimer’s disease patients with DAPI and antibodies against PU.1+ (myeloid/microglia) and NeuN+ (neurons). This evidence concerns the gene RBFOX3 and early-onset autosomal dominant Alzheimer disease.